<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01842789</url>
  </required_header>
  <id_info>
    <org_study_id>CP-00-0021</org_study_id>
    <nct_id>NCT01842789</nct_id>
  </id_info>
  <brief_title>Post Market Evaluation of Acessa With TAG</brief_title>
  <acronym>TAG</acronym>
  <official_title>Post Market Evaluation of the Acessa System With Targeting Animation Guidance (TAG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Acessa Health, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Acessa Health, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test both user preference and speed of targeting with the use
      of the Acessa System with Targeting Animation Guidance (TAG).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The intent of the TAG system is to assist the gynecologist in getting the tip of the Acessa
      Handpiece to the fibroid by creating an animated image overlay of the movements and
      placement.

      The study will be conducted in two parts:

      Part 1: User Preference Testing - users will be presented with various statements pertaining
      to the features of the system and asked to indicate their degree of agreement.

      Part 2: Time to target - will be measure by fibroid.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Results to date adequately demonstrated user preference and recovery time. Time to target (Part
    II) was not studied. .
  </why_stopped>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Physician Feedback Regarding TAG System Use During Surgery.</measure>
    <time_frame>Physicians have up to 1 hour after the procedure to fill out the questionnaire</time_frame>
    <description>Physician preference testing is assessed by the completion of a questionnaire using a 5 point rating system ranging from &quot;strongly agree&quot; (a rating of 5) to &quot;strongly disagree&quot; (a rating of 1) regarding the use of the TAG system. The questions included are in regards to ease of targeting, ease of visualizing the target, the addition of specific features that enhance user interface and the overall set-up.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Minutes From Visualizing the Target to Reaching the Target</measure>
    <time_frame>Intraoperative</time_frame>
    <description>To measure difference in time to target with and without the use of TAG. This is a time and motion study, with time measured at each stage of the procedure. The most important subject variable to consider was number of fibroids targeted, which influenced overall procedure time.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recovery Time</measure>
    <time_frame>1 to 2 months</time_frame>
    <description>Patients to be followed for 1 to 2 months post-treatment to evaluate recovery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Uterine Fibroids</condition>
  <arm_group>
    <arm_group_label>Acessa Procedure w/o TAG</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Acessa Procedure without the use of Targeting Animation Guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acessa Procedure with TAG</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Acessa Procedure with Targeting Animation Guidance</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acessa Procedure</intervention_name>
    <description>Acessa Procedure</description>
    <arm_group_label>Acessa Procedure w/o TAG</arm_group_label>
    <arm_group_label>Acessa Procedure with TAG</arm_group_label>
    <other_name>TAG</other_name>
    <other_name>Halt Procedure</other_name>
    <other_name>GFA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Women who:

          -  Are planning to undergo the Acessa procedure

          -  Are willing and able to comply with all procedures

          -  Are capable of providing informed consent

        Exclusion Criteria: Women who:

          -  In the medical judgement of the investigator should not participate in this study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald I Galen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Donald I Galen Consulting</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Donald I Galen Consulting</name>
      <address>
        <city>San Ramon</city>
        <state>California</state>
        <zip>94583</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hayhurst C, Byrne P, Eldridge PR, Mallucci CL. Application of electromagnetic technology to neuronavigation: a revolution in image-guided neurosurgery. J Neurosurg. 2009 Dec;111(6):1179-84. doi: 10.3171/2008.12.JNS08628.</citation>
    <PMID>19326991</PMID>
  </reference>
  <reference>
    <citation>Fried MP, Parikh SR, Sadoughi B. Image-guidance for endoscopic sinus surgery. Laryngoscope. 2008 Jul;118(7):1287-92. doi: 10.1097/MLG.0b013e31816bce76. Review.</citation>
    <PMID>18391767</PMID>
  </reference>
  <reference>
    <citation>Kr√ºcker J, Xu S, Glossop N, Viswanathan A, Borgert J, Schulz H, Wood BJ. Electromagnetic tracking for thermal ablation and biopsy guidance: clinical evaluation of spatial accuracy. J Vasc Interv Radiol. 2007 Sep;18(9):1141-50.</citation>
    <PMID>17804777</PMID>
  </reference>
  <reference>
    <citation>Garza Leal JG, Hernandez Leon I, Castillo Saenz L, Lee BB. Laparoscopic ultrasound-guided radiofrequency volumetric thermal ablation of symptomatic uterine leiomyomas: feasibility study using the Halt 2000 Ablation System. J Minim Invasive Gynecol. 2011 May-Jun;18(3):364-71. doi: 10.1016/j.jmig.2011.02.006.</citation>
    <PMID>21545960</PMID>
  </reference>
  <reference>
    <citation>Bergamini V, Ghezzi F, Cromi A, Bellini G, Zanconato G, Scarperi S, Franchi M. Laparoscopic radiofrequency thermal ablation: a new approach to symptomatic uterine myomas. Am J Obstet Gynecol. 2005 Mar;192(3):768-73.</citation>
    <PMID>15746670</PMID>
  </reference>
  <reference>
    <citation>Milic A, Asch MR, Hawrylyshyn PA, Allen LM, Colgan TJ, Kachura JR, Hayeems EB. Laparoscopic ultrasound-guided radiofrequency ablation of uterine fibroids. Cardiovasc Intervent Radiol. 2006 Jul-Aug;29(4):694-8.</citation>
    <PMID>16502165</PMID>
  </reference>
  <reference>
    <citation>Robles R, Aguirre VA, Argueta AI, Guerrero MR. Laparoscopic radiofrequency volumetric thermal ablation of uterine myomas with 12 months of follow-up. Int J Gynaecol Obstet. 2013 Jan;120(1):65-9. doi: 10.1016/j.ijgo.2012.07.023. Epub 2012 Oct 14.</citation>
    <PMID>23073229</PMID>
  </reference>
  <reference>
    <citation>Chudnoff SG, Levine DJ, Galen DI, et al. Prospective 12-month follow up of quality-of-life improvement following 135 consecutive cases laparoscopic and ultrasound-guided radiofrequency ablation of fibroids. J Minim Invasive Gynecol. 2012;19(Suppl):S45.</citation>
  </reference>
  <reference>
    <citation>Lee BB. Radiofrequency ablation of uterine fibroids; a new minimally invasive hysterectomy alternative. Obstet Gynecol. 2002;99(Suppl):S9.</citation>
  </reference>
  <reference>
    <citation>Chudnoff SG, Berman JM, Levine DJ, Harris M, Guido RS, Banks E. Outpatient procedure for the treatment and relief of symptomatic uterine myomas. Obstet Gynecol. 2013 May;121(5):1075-82. doi: 10.1097/AOG.0b013e31828b7962.</citation>
    <PMID>23635746</PMID>
  </reference>
  <reference>
    <citation>Macer JA. For uterine-sparing fibroid treatment, consider laparoscopic ultrasound-guided radiofrequency ablation. obmanagement.com Vol 25 No. 11 November 2013</citation>
  </reference>
  <results_reference>
    <citation>Galen DI. Electromagnetic image guidance in gynecology: prospective study of a new laparoscopic imaging and targeting technique for the treatment of symptomatic uterine fibroids. Biomed Eng Online. 2015 Oct 15;14:90. doi: 10.1186/s12938-015-0086-5.</citation>
    <PMID>26471917</PMID>
  </results_reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2013</study_first_submitted>
  <study_first_submitted_qc>April 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2013</study_first_posted>
  <results_first_submitted>May 27, 2017</results_first_submitted>
  <results_first_submitted_qc>June 21, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 19, 2017</results_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acessa</keyword>
  <keyword>Fibroids</keyword>
  <keyword>Halt</keyword>
  <keyword>Targeting Animation</keyword>
  <keyword>Image Overlay</keyword>
  <keyword>Radiofrequency Ablation</keyword>
  <keyword>RFA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Acessa Procedure w/o TAG</title>
          <description>Acessa Procedure without the use of Targeting Animation Guidance
Acessa Procedure: Acessa Procedure</description>
        </group>
        <group group_id="P2">
          <title>Acessa Procedure With TAG</title>
          <description>Acessa Procedure with Targeting Animation Guidance
Acessa Procedure: Acessa Procedure</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Acessa Procedure w/o TAG</title>
          <description>Acessa Procedure without the use of Targeting Animation Guidance
Acessa Procedure: Acessa Procedure</description>
        </group>
        <group group_id="B2">
          <title>Acessa Procedure With TAG</title>
          <description>Acessa Procedure with Targeting Animation Guidance
Acessa Procedure: Acessa Procedure</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="8"/>
            <count group_id="B3" value="18"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41.8" lower_limit="28.5" upper_limit="49.6"/>
                    <measurement group_id="B2" value="43.9" lower_limit="31.2" upper_limit="52.9"/>
                    <measurement group_id="B3" value="42.7" lower_limit="28.5" upper_limit="52.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Physician Feedback Regarding TAG System Use During Surgery.</title>
        <description>Physician preference testing is assessed by the completion of a questionnaire using a 5 point rating system ranging from ‚Äústrongly agree‚Äù (a rating of 5) to ‚Äústrongly disagree‚Äù (a rating of 1) regarding the use of the TAG system. The questions included are in regards to ease of targeting, ease of visualizing the target, the addition of specific features that enhance user interface and the overall set-up.</description>
        <time_frame>Physicians have up to 1 hour after the procedure to fill out the questionnaire</time_frame>
        <population>All subjects in whom TAG was used as an accessory system. This outcome measure was specific to this arm of the study only. Physicians provided feedback regarding use of the accessory system but did not provide feedback regarding the standard system without guidance. Physicians rated the system on a scale of 1 Strongly disagree to 5 Strongly agree.</population>
        <group_list>
          <group group_id="O1">
            <title>Acessa Procedure With TAG</title>
            <description>Acessa Procedure with Targeting Animation Guidance
Acessa Procedure: Acessa Procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Physician Feedback Regarding TAG System Use During Surgery.</title>
          <description>Physician preference testing is assessed by the completion of a questionnaire using a 5 point rating system ranging from ‚Äústrongly agree‚Äù (a rating of 5) to ‚Äústrongly disagree‚Äù (a rating of 1) regarding the use of the TAG system. The questions included are in regards to ease of targeting, ease of visualizing the target, the addition of specific features that enhance user interface and the overall set-up.</description>
          <population>All subjects in whom TAG was used as an accessory system. This outcome measure was specific to this arm of the study only. Physicians provided feedback regarding use of the accessory system but did not provide feedback regarding the standard system without guidance. Physicians rated the system on a scale of 1 Strongly disagree to 5 Strongly agree.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Transducer and handpiece dynamic animation was</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>The use of TAG enabled the ability to reach the fi</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Knowing the handpiece trajectory helped to tar</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>The transducer and handpiece dynamic animation hel</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>The use of TAG provided confidence when targeting</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Minutes From Visualizing the Target to Reaching the Target</title>
        <description>To measure difference in time to target with and without the use of TAG. This is a time and motion study, with time measured at each stage of the procedure. The most important subject variable to consider was number of fibroids targeted, which influenced overall procedure time.</description>
        <time_frame>Intraoperative</time_frame>
        <population>All participants undergoing treatment with Acessa (with or without targeting animation guidance).</population>
        <group_list>
          <group group_id="O1">
            <title>Acessa Procedure w/o TAG</title>
            <description>Acessa Procedure without the use of Targeting Animation Guidance
Acessa Procedure: Acessa Procedure</description>
          </group>
          <group group_id="O2">
            <title>Acessa Procedure With TAG</title>
            <description>Acessa Procedure with Targeting Animation Guidance
Acessa Procedure: Acessa Procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Minutes From Visualizing the Target to Reaching the Target</title>
          <description>To measure difference in time to target with and without the use of TAG. This is a time and motion study, with time measured at each stage of the procedure. The most important subject variable to consider was number of fibroids targeted, which influenced overall procedure time.</description>
          <population>All participants undergoing treatment with Acessa (with or without targeting animation guidance).</population>
          <units>Minutes per fibroid treated</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.9" lower_limit="8.9" upper_limit="65.0"/>
                    <measurement group_id="O2" value="25.2" lower_limit="15.1" upper_limit="45.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recovery Time</title>
        <description>Patients to be followed for 1 to 2 months post-treatment to evaluate recovery.</description>
        <time_frame>1 to 2 months</time_frame>
        <population>All subjects followed for 1 to 2 months post treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Acessa Procedure w/o TAG</title>
            <description>Acessa Procedure without the use of Targeting Animation Guidance
Acessa Procedure: Acessa Procedure</description>
          </group>
          <group group_id="O2">
            <title>Acessa Procedure With TAG</title>
            <description>Acessa Procedure with Targeting Animation Guidance
Acessa Procedure: Acessa Procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Recovery Time</title>
          <description>Patients to be followed for 1 to 2 months post-treatment to evaluate recovery.</description>
          <population>All subjects followed for 1 to 2 months post treatment.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.5" lower_limit="2" upper_limit="45"/>
                    <measurement group_id="O2" value="6" lower_limit="4" upper_limit="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 days post operative follow up</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Acessa Procedure w/o TAG</title>
          <description>Acessa Procedure without the use of Targeting Animation Guidance
Acessa Procedure: Acessa Procedure</description>
        </group>
        <group group_id="E2">
          <title>Acessa Procedure With TAG</title>
          <description>Acessa Procedure with Targeting Animation Guidance
Acessa Procedure: Acessa Procedure</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bowel obstruction</sub_title>
                <description>obstruction of the lower bowel approximately one month after the Acessa procedure</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Poor wound healing</sub_title>
                <description>For one subject, the Acessa procedure incision was found to be not healing properly approximately 10 days after the procedure. The severity of this complication was considered moderate, treated with medications, and resolved appropriately.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Laura Kemp, Clinical Affairs Consultant</name_or_title>
      <organization>Acessa Health, Inc.</organization>
      <phone>4083751465</phone>
      <email>lkemp@acessahealth.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

